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Background: People often modify oral solid dosage forms when they experience difficulty 
swallowing them. Modifying dosage forms may cause adverse effects to the patient, and the 
person undertaking the modification. Pharmacists are often the first point of contact for people 
in the general community seeking advice regarding medications. Nurses are at the forefront of 
administering medications to patients and are likely to be most directly affected by a patient’s 
swallowing ability, while general practitioners (GPs) are expected to consider swallowing 
abilities when prescribing medications.
Objective: To compare the perspectives and experiences of GPs, pharmacists, and nurses  regarding 
medication dosage form modification and their knowledge of medication modification.
Method: Questionnaires tailored to each profession were posted to 630 GPs, and links to an 
online version were distributed to 2,090 pharmacists and 505 nurses.
Results: When compared to pharmacists and GPs, nurses perceived that a greater proportion 
of the general community modified solid dosage forms. Pharmacists and GPs were most likely 
to consider allergies and medical history when deciding whether to prescribe or dispense 
a medicine, while nurses’ priorities were allergies and swallowing problems when administering 
medications. While nurses were more likely to ask their patients about their ability to swallow 
medications, most health professionals reported that patients “rarely” or “never” volunteered 
information about swallowing difficulties. The majority of health professionals would advise a 
patient to crush or split noncoated non-sustained-release tablets, and would consult colleagues 
or reference sources for sustained-release or coated tablets. Health professionals appeared to 
rely heavily upon the suffix attached to medication names (which suggest modified release 
properties) to identify potential problems associated with modifying medications.
Conclusion: The different professional roles and responsibilities of GPs, pharmacists, and nurses 
are associated with different perspectives of, and experiences with, people modifying medications 
in the general community and knowledge about consequences of medication modification.
Keywords: crushing tablets, opening capsules, dosage form modif ication, health 
professional
Introduction
Some individuals modify solid dosage forms such as tablets or capsules because they 
dislike or experience difficulties with swallowing medications.1,2 Medication modi-
fication is performed for patients with nasogastric or gastrostomy feeding tubes as 
solid dosage forms are not appropriate. Medication modification can also occur when 
nonstandard doses are prescribed, or if liquid dosage forms are unavailable.1,3 Modified 
solid dosage forms may also be used to covertly administer medications to patients 
who lack the mental capacity to make a decision about their treatment.4,5 Solid dosage 
Integrated Pharmacy Research and Practice 2014:3submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2
nguyen et al
forms such as tablets may be modified through crushing, split-
ting, or chewing, while capsules may be opened.1,6 Crushing 
or modifying a dosage form in most instances is considered 
“off-label use” as it may not fall under a product’s original 
license/registration. Consequently, any resulting liability 
falls with the prescriber and/or the person undertaking the 
modification.4,7
Dosage form modifications can be occupational hazards 
for the person modifying and administering the medica-
tion,8–11 and can increase the risk of clinically significant 
adverse effects for the patient. Altering solid dosage forms, 
eg, those with modified release properties, can affect the 
intended rate and extent of drug absorption. This increases 
the likelihood of adverse effects and toxicity, along with 
periods of subtherapeutic drug levels.12–14 There is concern 
that modifying solid dosage forms can also destroy coatings 
that protect the active ingredient, eg, drugs that are light sensi-
tive or that are acid labile, causing them to be inactivated or 
broken down before they reach the intended site of action.15 
Coatings can also be used to prevent drugs from causing side 
effects to the patient (eg, drugs that irritate the stomach can 
be enteric-coated),16 so modifying the solid dosage form may 
interfere with the coating’s intended function.
When solid dosage forms are modified, the active 
ingredient may be lost as part of the modification and 
administration process. For example, there may be loss of 
drug due to spillage, or powder sticking to the crushing 
equipment or medicine cup.6,17 There is general concern that 
this could cause inconsistent and/or incomplete dosing of 
the medication, leading to a reduction in efficacy, particu-
larly with drugs that have a narrow therapeutic window.1,6,7 
This issue can be compounded if the crushed or opened 
dosage form results in an unpalatable taste or texture.18,19 
Furthermore, cross contamination from residual drugs can 
occur if the uncleaned crushing equipment is shared among 
patients.20
It is generally advised that solid dosage forms should only 
be modified as a last resort.7 Potential alternatives include 
using the same drug that is commercially manufactured 
or extemporaneously compounded into a suitable dosage 
form,1,17 or by prescribing a different drug within the same 
therapeutic class that is formulated in an appropriate dosage 
form.21 Nevertheless, studies continuously report that patients 
and/or carers, along with health professionals, still modify 
solid dosage forms, even when more clinically appropriate 
alternatives are available.1,6,17,21
In relation to issues associated with medication use, 
pharmacists are often the first point of contact for patients 
in the community and other health professionals. However, 
there is little research on pharmacists’ perspectives, experi-
ences, and knowledge of dosage form modification. Most 
of the available research has investigated the perspective 
of the patient/carer,2,22–25 or nurses administering modified 
dosage forms.3,5,6,21 While pharmacists are mentioned in the 
studies, no research has directly focused on their experiences 
or perceptions regarding dosage form modifications. As 
such, it would be useful to gauge the perceptions, experi-
ences, and knowledge of pharmacists regarding dosage form 
modification, and how it might compare with other health 
professionals who are frequently involved with dosage form 
modifications.
The aim of this study was to explore and compare the 
perceptions, experiences, and knowledge of pharmacists, 
general practitioners (GPs), and nurses regarding the altera-
tion of medication dosage forms.
Methods
A self-administered survey was mailed to 630 GPs across 
Queensland, Australia, in April 2010, with 421 in the  Brisbane 
South Division of General Practice, 97 in the Capricornia 
Division of General Practice, and 112 in the Toowoomba 
GP Connections Division of General  Practice. A link to an 
online version of the survey was emailed to 505 nurses reg-
istered with the University of Queensland, School of Nursing 
and Midwifery’s alumni database in May 2010. The link 
was also distributed to 2,090 Queensland pharmacists in an 
e-newsletter from the Queensland branch of the Pharmaceuti-
cal Society of Australia.
The survey collected demographic information from the 
participants. The health professionals were asked for their 
perception of and experiences with people modifying 
their medication dosage forms in the general community. 
Participants were asked to estimate the prevalence of dosage 
form modification among the general community, questioned 
on how often they asked their patients about their swallow-
ing ability, and how often their patients advised them of 
any swallowing difficulties or modifications made to solid 
dosage forms. The survey also explored whether health 
professionals regularly discussed the issue of dosage form 
modifications, including the alternatives, with other health 
professionals, and the solutions they would offer patients 
who had difficulty swallowing a noncoated non-sustained-
release (non-SR) tablet, versus a sustained-release (SR) or 
coated tablet. Knowledge pertaining to altering dosage forms 
was investigated via the association of potential problems 
with the modification of eleven different medications. 
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Table 1 Demographics of the health professionals surveyed
Characteristics General 
practitioners 
n=121
Pharmacists 
n=173
Nurses 
n=58
sex ratio (M:F) 1.1:1  
(63:58)
1:1.19  
(60:113)
1:4.8 
(10:48)
age (years)
  30 4% 33% 66%
  31–40 15% 16% 5%
  41–50 27% 17% 9%
  51–60 41% 18% 16%
  .60 13% 16% 5%
Years in profession
  5 4% 28% 65%
  6–10 8% 13% 5%
  11–20 23% 12% 2%
  21–30 35% 18% 12%
  .30 30% 29% 16%
Professional location
  aged care – – 12%
  community – 65% 24%
  hospital – 19% 59%
  Other – 16% –
  accreditation – 39% –
Position
  assistant nurse – – 10%
   endorsed enrolled 
nurse
– – 2%
  Registered nurse – – 67%
  nurse practitioner – – 19%
  Midwife – – 2%
Note: “–” denotes not applicable.
Abbreviations: M, male; F, female.
Statistical analysis was conducted with Kendall’s tau-c test 
using SPSS 17.0 software (IBM Corporation, Armonk, NY, 
USA).
Ethical approval was obtained from the University of 
Queensland, School of Pharmacy Human Research Ethics 
Committee. The surveys were piloted on a group of pharma-
cists for appropriateness, readability, and understanding.
Results
Demographics
There was a relatively even distribution of males and females 
within the GP respondents, with 54% aged 51 years or above 
(Table 1). The age of the pharmacist respondents was more 
evenly distributed, and the majority of them were women 
(65%; 113/173) who worked in community pharmacy. The 
nurse respondents tended to be young female registered 
nurses practicing in hospitals, but representation from a range 
of backgrounds was obtained (Table 1).
Perceptions
Compared to pharmacists and GPs, nurses perceived that a 
greater proportion of the general community modified solid 
dosage forms. The most common estimate from nurses was 
that 30% of people in the community modified their medica-
tions, compared to 20% and 10% from GPs and pharmacists 
respectively (Figure 1). Few pharmacists (14%; 24/173) and 
GPs (13%; 15/119) considered that more than half of the 
general population modified their medications, whereas 39% 
(17/44) of nurses held this view.
Pharmacists and GPs ranked allergies and medical history 
as the most important patient factors to be considered when 
prescribing and dispensing a medication, with swallowing 
problems and patient weight more frequently rated as least 
important (Figure 2A and B). In contrast, the most important 
patient factors for nurses when administering medications 
were swallowing problems and allergies, with patient age and 
weight being of lesser importance (Figure 2C). Statistically, 
prioritization by the health professionals was different for swal-
lowing problems (P,0.001) and medical history (P=0.002) but 
not patient age, weight, and allergies. Pharmacists (P,0.001) 
and GPs (P,0.001) differed from nurses in their views on the 
importance of swallowing problems, and nurses (P,0.03) and 
pharmacists (P,0.001) differed from GPs in their perspectives 
on medical history (Figure 2).
experiences
The health professionals differed in their likelihood of asking 
patients if they had problems swallowing their medications 
(P=0.001). Nurses were more likely to ask their patients about 
their medication swallowing ability than pharmacists 
(P,0.001) and GPs (P,0.001). Patients were “often” or 
“always” asked about their swallowing capabilities by 53% 
of nurses, 14% of pharmacists, and 8% of GPs; while 43% 
of pharmacists, 32% of GPs, and 16% of nurses “rarely” or 
“never” asked their patients (Figure 3A).
When patients were not specifically asked about swallow-
ing difficulties, there was no significant difference (P=0.982) 
in the frequency at which patients volunteered this informa-
tion to the different groups of health professionals. Only 19% 
of nurses, 16% of GPs, and 7% of pharmacists reported that 
patients would “often” or “always” volunteer information 
about their swallowing difficulties, while patients would 
“rarely” or “never” voluntarily advise 51% of pharmacists, 
42% of GPs, and 36% of nurses about their medication 
swallowing difficulties (Figure 3B). GPs (44.6%) were more 
likely than pharmacists (5.2%) and nurses (6.9%) to only 
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ask certain subsets of the population (such as the elderly, 
children, or those with known esophageal disorders) about 
their swallowing ability.
The majority of GPs (66%) and pharmacists (56%) did not 
regularly discuss the modification of medications, including 
the alternatives, with other health professionals. This was 
in contrast to the majority of nurses (72%) who regularly 
discussed the alteration of medication dosage forms with 
other health professionals. The solution health professionals 
reportedly offered patients with difficulty swallowing non-SR 
and noncoated dosage forms was not significantly different 
(P=0.067), with the advice generally being to crush or split 
the tablet (Table 2). However, responses were different for SR 
or coated dosage forms (P,0.001). The majority of nurses 
reported referring patients to either a pharmacist or a doctor, 
while GPs and pharmacists would consult reference texts, or 
refer patients to each other (ie, GPs would refer patients to 
pharmacists, while pharmacists would refer patients to GPs). A 
small number of health professionals reported advising patients 
to crush or split SR or coated dosage forms (Table 2).
Knowledge
When asked to associate problems that may arise from the 
modification of some common medications, 93% of GPs, 
98% of pharmacists, and 84% of nurses attempted the 
 question (Table 3). Some health professionals did not pro-
vide an answer for all of the medications, so the percentage 
response was calculated based on the number of respondents 
for each drug individually.
More than half the respondents identified that altering 
dosage forms with modified release properties (eg, mor-
phine controlled-release [CR], isosorbide mononitrate SR, 
and verapamil SR) could lead to faster drug absorption, or 
an increase in adverse effects due to the change in release 
properties. Up to half the respondents identified concern with 
modifying drugs that have a narrow therapeutic index (eg, 
thyroxine, perhexiline, and carbamazepine), as incomplete 
dosing can lead to a reduction in efficacy. The majority of 
health professionals (82%–91%) identified that modifying 
enteric-coated diclofenac can cause stomach irritation, but 
only 40% of nurses, 62% of GPs, and 73% of pharmacists 
identified stomach irritation as a potential problem when 
modified ferrous sulphate tablets are administered to a patient. 
More pharmacists (75%) associated the modification of aza-
thioprine with causing harm to the administrator, compared 
to nurses (37%) and GPs (34%). However, few respondents 
overall identified that modifying antibiotics may also cause 
harm to the administrator as they can be an irritant and cause 
sensitization (Table 3).
Discussion
The perceptions, experiences and knowledge of health profes-
sionals on medication modification were closely associated with 
their professional roles. For instance, nurses are at the forefront 
of administering medications to patients, and are therefore 
most directly affected by swallowing problems. As such, when 
compared to pharmacists and GPs, nurses were more likely to 
perceive that the general community modified their medication 
0
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Figure 1 Health professionals’ estimate of the percentage of people in the general community that modified their medications.
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Figure 2 The influence of patient factors on the prescribing, dispensing, and administration of medications.
Notes: (A) general practitioners (n=121); (B) pharmacists (n=167); and (C) nurses (n=44).
Integrated Pharmacy Research and Practice 2014:3submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
6
nguyen et al
dosage forms. Similarly, nurses rated swallowing ability as the 
most important patient factor considered when administering a 
medication, in contrast to GPs and pharmacists.
The health professionals surveyed estimated that between 
10%–30% of people would modify their medications.  Previous 
studies have found patient or carer reported prevalence of 
medication modification in the general community to be 
between 24%23 and 68%.24 This discrepancy may be because 
the majority of respondents reported that their patients either 
“rarely” or “sometimes” informed them of swallowing 
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Figure 3 Experiences of health professionals asking about patients’ swallowing abilities, and being told by patients about swallowing difficulties.
Notes: The frequency of health professionals (A) asking patients about their swallowing ability (general practitioners, n=121; pharmacists, n=173; and nurses, n=44); and 
(B) being told about swallowing difficulties by their patients (general practitioners, n=118; pharmacists, n=173; and nurses, n=44).
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difficulties voluntarily, which is consistent with reports in 
literature.19,26 This highlights an opportunity for health profes-
sionals to discuss and ask their patients about swallowing issues 
as they themselves only “sometimes” asked their patients, 
which might also have contributed to the health professionals’ 
low perception of the prevalence of medication modification 
in the general community.
Overall, GPs were least likely to “often” or “always” ask 
patients about swallowing problems, but were most likely to 
target this questioning to patients who were predisposed, or 
who had pre-existing conditions that would precipitate swal-
lowing problems. This indicates that GPs are aware swallowing 
problems occur more frequently in certain cohorts, but could 
also suggest that they may not consider people in the general 
community outside of these cohorts to have swallowing dif-
ficulties. Similarly, the comparatively smaller proportion 
of pharmacists and nurses that only ask certain subsets of 
the population about their swallowing ability suggests that 
pharmacists and nurses are generally aware that swallowing 
problems exist in the wider community. Alternatively, they are 
unaware that there are certain subsets of people in the general 
community who are more prone to experiencing swallowing 
difficulties. It is also possible these findings demonstrate that 
discussing swallowing problems has become an “orphan task.” 
This is when the issue does not clearly fall within the realms of 
any one health professionals’ defined tasks or responsibilities, 
so each group of health professionals assume or expect that 
another health professional involved in the patient’s care will 
take responsibility and ask about swallowing problems.19,27 
These findings warrant further investigations before any con-
clusions may be drawn as there is currently no data to suggest 
one interpretation is more correct than the other.
The health professionals’ work environment also appeared 
to influence the solutions they provided to patients who had 
difficulty swallowing. The solutions offered to patients who 
had difficulty swallowing a non-SR noncoated tablet were 
similar among the three groups of health professionals. While 
crushing non-SR noncoated tablets may appear to be a reason-
able approach, as stated previously, there are instances where 
this may not be appropriate (eg, medications that have a nar-
row therapeutic index). The health professionals differed in 
their approach when a SR or coated tablet was involved. The 
majority of the nurse respondents reported that they would 
“regularly” discuss issues pertaining to medication modifi-
cations with other health professionals, which is consistent 
with the majority of nurses reporting that they would refer a 
patient who had trouble swallowing a modified release tablet 
to a pharmacist or GP. This may be explained by the different 
workplace arrangements since most of the nurse respondents 
in this study worked in a hospital setting, compared to the 
majority of pharmacists working in community pharmacy, 
and GPs working in general practice. The hospital setting 
allows nurses to work in close proximity with other health 
professionals, fostering a multidisciplinary environment that 
facilitates discussions, in contrast to the workplace of com-
munity pharmacists and GPs, which may be less conducive 
to such interactions. As such, the GPs and pharmacists in this 
study were more likely to consult reference sources, instead 
of consulting with their peers.
The majority of nurse respondents in this study reported 
that they would consult a pharmacist or GP in relation to a SR 
or coated tablet. This is in contrast to published literature that 
report nurses performing modification to dosage forms that 
were unauthorized, were conducted for no apparent reason, 
and where modification could have been avoided as more suit-
able alternate forms of the medication was available.3,17,28 The 
discrepancy in these findings may be due to the self-reporting 
nature of this survey, compared to the use of focus groups 
and/or the observational nature of previously published 
studies. Nevertheless, it is of concern that a minority in all 
three groups of health professionals reported they would 
recommend patients to crush or split SR or coated tablets. It 
Table 2 The solution health professionals would offer patients who could not swallow a non-sustained-release and noncoated tablet, 
in comparison to a sustained-release or a coated tablet
Solution General Practitioners Pharmacists Nurses
Non-SR and 
noncoated (n=114)
SR or coated 
(n=107)
Non-SR and  
noncoated (n=173)
SR or coated 
(n=173)
Non-SR and  
noncoated (n=58)
SR or coated 
(n=58)
Refer to doctor – – 1% 32% 0% 31%
Refer to pharmacist 15% 25% – – 19% 50%
Refer to texts 24% 49% 36% 58% 16% 7%
crush the tablet 46% 3% 24% 1% 22% 2%
split the tablet 26% 2% 35% 0% 36% 2%
Othera 7% 32% 5% 9% 7% 8%
Notes: aRefer to speech pathologist, or use alternative formulation or medication. “–” indicates results not determined.
Abbreviations: non-sR, non-sustained-release; sR, sustained-release.
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is inferred that health professionals had the most difficulty 
identifying problems associated with modifying perhexiline, 
thyroxine, azathioprine, carbamazepine, and metronidazole, 
as they more frequently omitted to provide an answer for these 
drugs (Table 3). This group of drugs does not have modified 
release properties, and therefore did not have a suffix such as 
“CR,” “SR,” or “EC,” which represent “controlled-release,” 
“sustained-release,” and “enteric-coated,” respectively. This 
suggests that health professionals are aware of the potential 
issues involved with altering medication dosage forms, 
particularly those with modified release properties, but they 
had to rely on the suffix of the drug names to identify those 
types of drugs. This is concerning as the suffix of medica-
tions are often  omitted on prescriptions,29 which can lead 
unsuspecting health  professionals to unintentionally modify 
medications that can lead to clinically significant adverse 
patient outcomes.12 This suggests that many health profes-
sionals may be less able to identify the problems associated 
with the alteration of medications that do not have modified 
release properties.
limitations
The self-reporting nature of the survey relies on the accuracy 
and honesty of the respondents, so results may deviate from 
what actually occurs in practice. The self-selection nature of 
the recruitment process also provides a potential bias with 
“motivated responders” perhaps providing different informa-
tion to targeted responders. The small sample groups may 
Table 3 Pharmacist, general practitioner, and nurse responses to a request to link potential outcomes resulting from the modification 
of some common medications
Drug Faster drug 
absorption
Increase  
adverse effects
Hazard to 
administrator
Stomach 
irritation
Reduced  
efficacy
Number of 
respondents
Pharmacist respondents
  amoxycillin clavulanic acid 21% 35% 3% 60% 24% 146/173
  azathioprine 21% 26% 75% 22% 7% 149/173
  carbamazepine 53% 46% 11% 21% 27% 135/173
  Diclofenac ec 22% 49% 2% 91% 12% 167/173
  Ferrous sulphate sR 36% 49% 1% 73% 2% 166/173
  Isosorbide mononitrate sR 71% 56% 11% 2% 45% 160/173
  Metronidazole 18% 48% 1% 70% 10% 141/173
  Morphine cR 83% 62% 12% 5% 30% 167/173
  Perhexiline 41% 54% 15% 18% 23% 114/173
  Thyroxine 37% 14% 3% 8% 52% 132/173
  Verapamil sR 76% 58% 9% 6% 36% 160/173
general practitioner respondents
  amoxycillin clavulanic acid 23% 42% 0% 54% 27% 97/121
  azathioprine 23% 35% 34% 19% 24% 74/121
  carbamazepine 53% 52% 5% 8% 34% 79/121
  Diclofenac ec 37% 45% 6% 84% 15% 102/121
  Ferrous sulphate sR 31% 46% 2% 62% 23% 98/121
  Isosorbide mononitrate sR 75% 55% 8% 0% 44% 96/121
  Metronidazole 24% 49% 0% 41% 27% 82/121
  Morphine cR 75% 57% 9% 6% 36% 108/121
  Perhexiline 36% 54% 7% 10% 20% 59/121
  Thyroxine 30% 21% 3% 6% 56% 70/121
  Verapamil sR 71% 51% 7% 6% 46% 101/121
nurse respondents
  amoxycillin clavulanic acid 22% 26% 9% 74% 26% 46/58
  azathioprine 24% 32% 37% 21% 16% 38/58
  carbamazepine 37% 37% 16% 21% 50% 38/58
  Diclofenac ec 24% 36% 9% 82% 20% 45/58
  Ferrous sulphate sR 49% 38% 7% 40% 42% 45/58
  Isosorbide mononitrate sR 64% 47% 9% 11% 45% 47/58
  Metronidazole 27% 32% 2% 55% 20% 44/58
  Morphine cR 71% 45% 16% 14% 39% 49/58
  Perhexiline 20% 40% 20% 23% 23% 35/58
  Thyroxine 30% 30% 14% 16% 52% 44/58
  Verapamil sR 57% 52% 13% 11% 39% 46/58
Abbreviations: cR, controlled-release; ec, enteric-coated; sR, sustained-release.
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make it difficult to extrapolate conclusions from this study; 
however, it can provide an indication of views and experi-
ences of these groups of health professionals.
Conclusion
The differing professional roles of GPs, pharmacists, and 
nurses are associated with different perceptions, experiences 
and knowledge of dosage form modification. While health 
professionals appear to be generally aware of problems asso-
ciated with modifying dosage forms, it is likely that potential 
adverse events due to modification of dosage forms can be 
prevented via more proactive discussions with patients or 
carers, and through continuing professional education.
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